TY - JOUR
T1 - Pro-inflammatory cytokines enhance ERAD and ATF6α pathway activity in salivary glands of Sjögren's syndrome patients
AU - Barrera, María José
AU - Aguilera, Sergio
AU - Castro, Isabel
AU - Cortés, Juan
AU - Bahamondes, Verónica
AU - Quest, Andrew F.G.
AU - Molina, Claudio
AU - González, Sergio
AU - Hermoso, Marcela
AU - Urzúa, Ulises
AU - Leyton, Cecilia
AU - González, María Julieta
N1 - Funding Information:
We thank all the patients who participated in this study. We gratefully acknowledge Professor Bruce Baum (NIDCR, NIH, Bethesda, MD, USA) for providing HSG cells, Dr. Patricia Burgos (Facultad de Medicina, Universidad Austral de Chile, Chile) for providing EerI, Dr. Stefana-Maria Petrescu (Institute of Biochemistry of Romanian Academy, Bucharest, Romania) for providing antibody anti-EDEM1, Dr. Claudio Hetz and Dr. René Vidal (Facultad de Medicina, Universidad de Chile) for providing PNGase F, plasmid pAAV_ATF6f and antibody anti-ATF6α, Dr. Mario Galindo (Facultad de Medicina, Universidad de Chile) for providing ELISA microplate reader and Dr. Julio Tapia (Facultad de Medicina, Universidad de Chile) for providing MTS/PMS solutions. Supported by Fondecyt-Chile [# 1160015 and 1120062 ] (MJG, SA, CM, SG), PhD fellowship Conicyt-Chile (MJB and JC), CONICYT-FONDAP [# 15130011 ] (AFGQ).
Publisher Copyright:
© 2016 Elsevier Ltd
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Salivary gland (SG) acinar-cells are susceptible to endoplasmic reticulum (ER) stress related to their secretory activity and the complexity of synthesized secretory products. SGs of Sjögren's syndrome patients (SS)-patients show signs of inflammation and altered proteostasis, associated with low IRE1α/XBP-1 pathway activity without avert increases in apoptosis. Acinar-cells may avoid apoptosis by activation of the ATF6α pathway and ER-associated protein degradation (ERAD). The aim of this study was to evaluate the role of pro-inflammatory cytokines in ATF6α pathway/ERAD activation and cell viability in labial salivary glands (LSG) of SS-patients. In biopsies from SS-patients increased ATF6α signaling pathway activity, as evidenced by generation of the ATF6f cleavage fragment, and increased expression of ERAD machinery components, such as EDEM1, p97, SEL1L, gp78, UBE2J1, UBE2G2, HERP and DERLIN1, were observed compared to controls. Alternatively, for pro- (active-caspase-3) and anti-apoptotic (cIAP2) markers no significant difference between the two experimental groups was detected. Increased presence of ATF6f and ERAD molecules correlated significantly with increased expression of pro-inflammatory cytokines. These observations were corroborated in vitro in 3D-acini treated with TNF-α and/or IFN-γ, where an increase in the expression and activation of the ATF6α sensor and ERAD machinery components was detected under ER stress conditions, while changes in cell viability and caspase-3 activation were not observed. Cytokine stimulation protected cells from death when co-incubated with an ERAD machinery inhibitor. Alternatively, when cytokines were eliminated from the medium prior to ERAD inhibition, cell death increased, suggesting that the presence of pro-inflammatory cytokines in the medium is essential to maintain cell viability. In conclusion, the ATF6α pathway and the ERAD machinery are active in LSG of SS-patients. Both were also activated by TNF-α and IFN-γ in vitro in 3D-acini and aided in preventing apoptosis. IFN-γ levels were elevated in SS-patients and UPR responses triggered in vitro by this cytokine closely matched those observed in LSG from SS-patients, suggesting that cytokines may induce ER stress.
AB - Salivary gland (SG) acinar-cells are susceptible to endoplasmic reticulum (ER) stress related to their secretory activity and the complexity of synthesized secretory products. SGs of Sjögren's syndrome patients (SS)-patients show signs of inflammation and altered proteostasis, associated with low IRE1α/XBP-1 pathway activity without avert increases in apoptosis. Acinar-cells may avoid apoptosis by activation of the ATF6α pathway and ER-associated protein degradation (ERAD). The aim of this study was to evaluate the role of pro-inflammatory cytokines in ATF6α pathway/ERAD activation and cell viability in labial salivary glands (LSG) of SS-patients. In biopsies from SS-patients increased ATF6α signaling pathway activity, as evidenced by generation of the ATF6f cleavage fragment, and increased expression of ERAD machinery components, such as EDEM1, p97, SEL1L, gp78, UBE2J1, UBE2G2, HERP and DERLIN1, were observed compared to controls. Alternatively, for pro- (active-caspase-3) and anti-apoptotic (cIAP2) markers no significant difference between the two experimental groups was detected. Increased presence of ATF6f and ERAD molecules correlated significantly with increased expression of pro-inflammatory cytokines. These observations were corroborated in vitro in 3D-acini treated with TNF-α and/or IFN-γ, where an increase in the expression and activation of the ATF6α sensor and ERAD machinery components was detected under ER stress conditions, while changes in cell viability and caspase-3 activation were not observed. Cytokine stimulation protected cells from death when co-incubated with an ERAD machinery inhibitor. Alternatively, when cytokines were eliminated from the medium prior to ERAD inhibition, cell death increased, suggesting that the presence of pro-inflammatory cytokines in the medium is essential to maintain cell viability. In conclusion, the ATF6α pathway and the ERAD machinery are active in LSG of SS-patients. Both were also activated by TNF-α and IFN-γ in vitro in 3D-acini and aided in preventing apoptosis. IFN-γ levels were elevated in SS-patients and UPR responses triggered in vitro by this cytokine closely matched those observed in LSG from SS-patients, suggesting that cytokines may induce ER stress.
KW - Cytokines
KW - ERAD
KW - Endoplasmic reticulum stress
KW - Salivary glands
KW - Sjögren's syndrome
KW - UPR
UR - http://www.scopus.com/inward/record.url?scp=84995609172&partnerID=8YFLogxK
U2 - 10.1016/j.jaut.2016.07.006
DO - 10.1016/j.jaut.2016.07.006
M3 - Article
C2 - 27461470
AN - SCOPUS:84995609172
SN - 0896-8411
VL - 75
SP - 68
EP - 81
JO - Journal of Autoimmunity
JF - Journal of Autoimmunity
ER -